Brain and Vertebral Column

Chapter

Abstract

Palliative neurosurgery has benefited from recent technological advances allowing safer and less invasive procedures aimed at relieving symptoms from advanced disease. Conditions treated include malignant glioma, cerebral and spinal metastases, hydrocephalus, malignant meningitis and cancer-related pain.

References

  1. 1.
    Dunn GP. Surgical palliative care: recent trends and developments. Surg Clin North Am. 2011;91(2):277–92, vii.PubMedCrossRefGoogle Scholar
  2. 2.
    Wrensch M, Minn Y, Chew T, Bondy M, Berger MS. Epidemiology of primary brain tumors: current concepts and review of the literature. Neuro Oncol. 2002;4(4):278–99.PubMedCentralPubMedGoogle Scholar
  3. 3.
    Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO, European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups, National Cancer Institute of Canada Clinical Trials Group. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352(10):987–96.PubMedCrossRefGoogle Scholar
  4. 4.
    Vogelbaum MA. Does extent of resection of a glioblastoma matter? Clin Neurosurg. 2012;59:79–81.PubMedCrossRefGoogle Scholar
  5. 5.
    Sanai N, Polley MY, McDermott MW, Parsa AT, Berger MS. An extent of resection threshold for newly diagnosed glioblastomas. J Neurosurg. 2011;115(1):3–8.PubMedCrossRefGoogle Scholar
  6. 6.
    Wirtz CR, Albert FK, Schwaderer M, Heuer C, Staubert A, Tronnier VM, Knauth M, Kunze S. The benefit of neuronavigation for neurosurgery analyzed by its impact on glioblastoma surgery. Neurol Res. 2000;22(4):354–60.PubMedGoogle Scholar
  7. 7.
    Kubben PL, ter Meulen KJ, Schijns OE, ter Laak-Poort MP, van Overbeeke JJ, van Santbrink H. Intraoperative MRI-guided resection of glioblastoma multiforme: a systematic review. Lancet Oncol. 2011;12(11):1062–70.PubMedCrossRefGoogle Scholar
  8. 8.
    Senft C, Franz K, Blasel S, Oszvald A, Rathert J, Seifert V, Gasser T. Influence of iMRI-guidance on the extent of resection and survival of patients with glioblastoma multiforme. Technol Cancer Res Treat. 2010;9(4):339–46.PubMedGoogle Scholar
  9. 9.
    Colditz MJ, Jeffree RL. Aminolevulinic acid (ALA)-protoporphyrin IX fluorescence guided tumour resection. Part 1: clinical, radiological and pathological studies. J Clin Neurosci. 2012;19(11):1471–4.PubMedCrossRefGoogle Scholar
  10. 10.
    Bourgeois M, Sainte-Rose C, Lellouch-Tubiana A, Malucci C, Brunelle F, Maixner W, Cinalli G, Pierre-Kahn A, Renier D, Zerah M, Hirsch JF, Goutières F, Aicardi J. Surgery of epilepsy associated with focal lesions in childhood. J Neurosurg. 1999;90(5):833–42.PubMedCrossRefGoogle Scholar
  11. 11.
    Packer RJ, Sutton LN, Patel KM, Duhaime AC, Schiff S, Weinstein SR, Gaillard WD, Conry JA, Schut L. Seizure control following tumor surgery for childhood cortical low-grade gliomas. J Neurosurg. 1994;80(6):998–1003.PubMedCrossRefGoogle Scholar
  12. 12.
    Posner JB, Chernik NL. Intracranial metastases from systemic cancer. Adv Neurol. 1978;19:579–92.PubMedGoogle Scholar
  13. 13.
    Barnholtz-Sloan JS, Sloan AE, Davis FG, Vigneau FD, Lai P, Sawaya RE. Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System. J Clin Oncol. 2004;22(14):2865–72.PubMedCrossRefGoogle Scholar
  14. 14.
    Schouten LJ, Rutten J, Huveneers HA, Twijnstra A. Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma. Cancer. 2002;94(10):2698–705.PubMedCrossRefGoogle Scholar
  15. 15.
    Zimm S, Wampler GL, Stablein D, Hazra T, Young HF. Intracerebral metastases in solid-tumor patients: natural history and results of treatment. Cancer. 1981;48(2):384–94.PubMedCrossRefGoogle Scholar
  16. 16.
    Bindal RK, Sawaya R, Leavens ME, Lee JJ. Surgical treatment of multiple brain metastases. J Neurosurg. 1993;79(2):210–6.PubMedCrossRefGoogle Scholar
  17. 17.
    Breneman JC, Warnick RE, Albright Jr RE, Kukiatinant N, Shaw J, Armin D, Tew Jr J. Stereotactic radiosurgery for the treatment of brain metastases. Results of a single institution series. Cancer. 1997;79(3):551–7.PubMedCrossRefGoogle Scholar
  18. 18.
    Shaw E, Scott C, Souhami L, Dinapoli R, Kline R, Loeffler J, Farnan N. Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90-05. Int J Radiat Oncol Biol Phys. 2000;47(2):291–8.PubMedCrossRefGoogle Scholar
  19. 19.
    Wakai S, Yamakawa K, Manaka S, Takakura K. Spontaneous intracranial hemorrhage caused by brain tumor: its incidence and clinical significance. Neurosurgery. 1982;10(4):437–44.PubMedCrossRefGoogle Scholar
  20. 20.
    Kondziolka D, Bernstein M, Resch L, Tator CH, Fleming JF, Vanderlinden RG, Schutz H. Significance of hemorrhage into brain tumors: clinicopathological study. J Neurosurg. 1987;67(6):852–7.PubMedCrossRefGoogle Scholar
  21. 21.
    Jones NR, Blumbergs PC. Intracranial haemorrhage from meningiomas: a report of five cases. Br J Neurosurg. 1989;3(6):691–8.PubMedCrossRefGoogle Scholar
  22. 22.
    Gonda DD, Kim TE, Warnke PC, Kasper EM, Carter BS, Chen CC. Ventriculoperitoneal shunting versus endoscopic third ventriculostomy in the treatment of patients with hydrocephalus related to metastasis. Surg Neurol Int. 2012;3:97.PubMedCentralPubMedCrossRefGoogle Scholar
  23. 23.
    Chen CC, Kasper E, Warnke P. Palliative stereotactic-endoscopic third ventriculostomy for the treatment of obstructive hydrocephalus from cerebral metastasis. Surg Neurol Int. 2011;2:76.PubMedCentralPubMedCrossRefGoogle Scholar
  24. 24.
    Clarke JL, Perez HR, Jacks LM, Panageas KS, Deangelis LM. Leptomeningeal metastases in the MRI era. Neurology. 2010;74(18):1449–54.PubMedCentralPubMedCrossRefGoogle Scholar
  25. 25.
    Rosen ST, Aisner J, Makuch RW, Matthews MJ, Ihde DC, Whitacre M, Glatstein EJ, Wiernik PH, Lichter AS, Bunn Jr PA. Carcinomatous leptomeningitis in small cell lung cancer: a clinicopathologic review of the National Cancer Institute experience. Medicine (Baltimore). 1982;61(1):45–53.CrossRefGoogle Scholar
  26. 26.
    Chamberlain MC. Neoplastic meningitis: diagnosis and treatment. In: Richard Winn H, editor. Youman’s neurological surgery. 5th ed. Philadelphia: Saunders; 2004.Google Scholar
  27. 27.
    Quan GM, Vital JM, Aurouer N, Obeid I, Palussière J, Diallo A, Pointillart V. Surgery improves pain, function and quality of life in patients with spinal metastases: a prospective study on 118 patients. Eur Spine J. 2011;20(11):1970–8.PubMedCentralPubMedCrossRefGoogle Scholar
  28. 28.
    Zairi F, Arikat A, Allaoui M, Marinho P, Assaker R. Minimally invasive decompression and stabilization for the management of thoracolumbar spine metastasis. J Neurosurg Spine. 2012;17(1):19–23.PubMedCrossRefGoogle Scholar
  29. 29.
    Burton AW, Rhines LD, Mendel E. Vertebroplasty and kyphoplasty: a comprehensive review. Neurosurg Focus. 2005;18(3):e1.PubMedCrossRefGoogle Scholar
  30. 30.
    Eckel TS, Olan W. Vertebroplasty and vertebral augmentation techniques. Tech Vasc Interv Radiol. 2009;12(1):44–50.PubMedCrossRefGoogle Scholar
  31. 31.
    Veeravagu A, Lieberson RE, Mener A, Chen YR, Soltys SG, Gibbs IC, Adler JR, Tian AG, Chang SD. CyberKnife stereotactic radiosurgery for the treatment of intramedullary spinal cord metastases. J Clin Neurosci. 2012;19(9):1273–7.PubMedCrossRefGoogle Scholar
  32. 32.
    Fleming HW. Palliative neurosurgical methods. Cal West Med. 1927;27(3):386.PubMedCentralPubMedGoogle Scholar
  33. 33.
    Gadgil N, Viswanathan A. DREZotomy in the treatment of cancer pain: a review. Stereotact Funct Neurosurg. 2012;90(6):356–60.PubMedCrossRefGoogle Scholar
  34. 34.
    Wagemans FM, Zuurmond WA, De Lange J. Long-term spinal opioid therapy in terminally ill cancer pain patients. Oncologist. 1997;2:70–5.PubMedGoogle Scholar
  35. 35.
    Singh M, Cugati G, Singh P, Singh AK. Programmable morphine pump (an intrathecal drug delivery system) – a promising option for pain relief and palliation in cancer patients. Indian J Med Paediatr Oncol. 2012;33(1):58–9.PubMedCentralPubMedCrossRefGoogle Scholar
  36. 36.
    Lihua P, Su M, Zejun Z, Ke W, Bennett MI. Spinal cord stimulation for cancer-related pain in adults. Cochrane Database Syst Rev. 2013;(2):CD009389.Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2014

Authors and Affiliations

  1. 1.Department of SurgeryUniversity of AdelaideAdelaideAustralia

Personalised recommendations